"We rarely see trial stage ASX companies value in line with US peers."
True, but vla topped $500m, and they had one drug with a limited market. And it appears as though Merck have mothballed it!
"We rarely see trial stage ASX companies value in line with US...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
-0.002(4.76%) |
Mkt cap ! $32.21M | |||
| Open | High | Low | Value | Volume |
| 4.2¢ | 4.2¢ | 4.0¢ | $14.80K | 363.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 182421 | 4.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 7143 | 1 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.0¢ |
Change
-0.002 ( 4.76 %) |
||||
| Open | High | Low | Volume | ||
| 4.0¢ | 4.2¢ | 4.0¢ | 211281 | ||
| Last updated 15.43pm 14/05/2024 ? | |||||
| PTX (ASX) Chart |